Frontlight ResearchEarly access
Trial site
Cancer Institute Hospital of JFCR
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Acute lymphoblastic leukaemia1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Mesothelioma1 trial
- Ovarian cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 34 trials
- Phase 1/22 trials
- Status
- Active, not recruiting3 trials
- Recruiting2 trials
- Completed1 trial
- Lead sponsor
- Taiho Oncology, Inc.2 trials
- Genmab1 trial
- Innovent Biologics (Suzhou) Co. Ltd.1 trial
- National Cancer Center Hospital East1 trial
- Takara Bio Inc.1 trial
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Active, not recruiting
Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Cervical cancer1 recruiting
- Endometrial cancer1 recruiting
- Mesothelioma1 recruiting
- Ovarian cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026